CHERYL WALSH: Open Payments
NPI 1780986372 · SPRINGDALE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$59,958 in 243 payments from 22 companies in 2025. Trend: 2023 $2,700 · 2024 $34,571 · 2025 $59,958
Speaker / faculty: $43,607Food & beverage: $6,738Travel & lodging: $6,634Consulting: $2,970Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 70 | $45,935 |
| Phathom Pharmaceuticals, Inc. | 18 | $6,743 |
| Madrigal Pharmaceuticals | 14 | $3,785 |
| ABBVIE INC. | 50 | $904 |
| Janssen Scientific Affairs, LLC | 8 | $615 |
| Regeneron Healthcare Solutions, Inc. | 10 | $430 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $187 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $171 |
| Gilead Sciences, Inc. | 9 | $160 |
| Ipsen Biopharmaceuticals, Inc | 8 | $157 |
Products named: TREMFYA, VOQUEZNA, STELARA, DUPIXENT, REZDIFFRA, RINVOQ, SKYRIZI, IQIRVO.
Industry payments across AR — which companies pay providers there.
